Drug manufacturer Sun Pharmaceutical has posted a net profit of Rs 1265 crore for the year ended March 31, 2009, up 25%, compared to Rs 1014 crore for the year ended March 31, 2008.

Further, the company's total income has also surged from Rs 3170 crore for the year ended March 31, 2008 to Rs 3928 crore for the year ended March 31, 2009.
 
On consolidated basis, the firm has posted a net profit of Rs 1818 crore for the year ended March 31, 2009 as compared to Rs 1487 crore for the year ended March 31, 2008.  

While, its total income has increased from Rs 3387 crore for the year ended March 31, 2008 to Rs 4359 crore for the year ended March 31, 2009.
 
The board of directors of the company at its meeting held on May 30, 2009, inter alia, has recommended payment of dividend of Rs 13.75 per equity share of Rs 5/- each of the Company for the year ended March 31, 2009.

However the decision is subject to the approval of the members at the ensuing Annual General Meeting of the Company.